Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

NCT04768075 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Non-Small-Cell Lung Cancer

Interventions

DRUG: Camrelizumab
DRUG: Placebo
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Pemetrexed
DRUG: Paclitaxel
DRUG: Albumin paclitaxel

Sponsor

Guangdong Association of Clinical Trials